• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
banner-ngs

NGS

Credence Genomics can be referred to as the gold standard opportunity provider in the discipline of genetic research in Sri Lanka.  Our laboratory is the only one of its kind, thus marking the dawn of new era in genetic research.  We believe that genetic research is the key element to better understanding of human diseases, and our aim is to bring home the leading technologies of the world, to help our researchers to discover and thrive.  Our attempt is to create an interdisciplinary hub that will connect researchers, both experimentalists and bioinformaticians, along with physicians and community representatives in order to develop a common genomic language.

Our research scope

Our research scope covers all aspects of genetic disorders, cancer studies, metagenomics, de novo sequencing, whole genome sequencing (small genomes), personalized medicine and cell free DNA studies.  All provided at an affordable rate.  Researchers will be able to experience the groundbreaking technologies, highlight exciting challenges, debate and disseminate knowledge via our facilities creating an open forum for future genetic research.

We are happy to welcome you to discover a new realm of genetic research.  Experience Next Generation Sequencing – divulge the technology with us, today.

businessdesk__1221487733_science

Next-Generation Sequencing

Modern scientific discoveries that resulted from the application of next generation DNA sequencing technologies highlight the prominent influence of these massively parallel platforms of genetics.  The throughput, scalability, coverage and accuracy is very high in NGS.  Latest improvements in sequencing technologies have made it possible to generate a large amount of data quickly and cost-effectively.  When compared with the throughput and resource constraints in traditional methods, NGS provides investigators with the required capability for analyzing large panel of genes or whole genomes in a single run.

NGS offers an ideal platform for comprehensive mutation analysis of constitutional disorders (germline variations) and cancer diagnostics (somatic variations).  With the rapid growth of this groundbreaking technology, clinical laboratories are now able to facilitate comprehensive gene panels for several complex inherited disorders. Therefore, the field of cancer biology has rapidly developed with better understanding of tumor-suppressor genes and oncogenes involved in different types of tumors, overcoming inherent limitations of conventional sequencing technologies.  NGS testing has also come across in clinical infectious disease testing, by sequencing hypervariable the bacterial 16S rRNA gene region as well as ITS gene sequences in fungi.  NGS testing has a broad spectrum in clinical applications and holds promises in providing newer insights into molecular biology deciphering the nature of human disease.

Key points

  • Pioneering lab for genetic research set up by Credence Genomics
  • Wide ranging, affordable research scope
  • Gather large amounts of data quickly and cost effectively with NGS
  • NGS offers a platform for a wide variety of applications
  • NGS has great potential for the wellness of mankind

Did you know

Credence Genomics is well placed to thoroughly understand and help find cures for common human diseases with its advanced genetics research lab right here in Sri Lanka.

Get in touch

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Phone: 011 2890687 / 011 2818370
Hotline: +94 71 038 0011
Email: info@credencegenomics.com

Search...

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

News Archive

© Credence Genomics 2021. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close